Extremely premature infants are a highly vulnerable patient group that might be exposed to a vast number of dietary and environmental contaminants, which may impact their health trajectories. This study assessed xenobiotic exposures in 26 extremely premature infants, with a special focus on dietary mycotoxins, using a dual analytical approach combining four sensitive, targeted LC-MS/MS methods and one non-targeted high-resolution mass spectrometry (HR-MS) assay. A total of 187 matched biological samples comprising breast milk (n = 35), plasma (n = 48), urine (n = 52), and stool (n = 52) collected at 7 and 28 days post-partum were subjected to mycotoxin analysis by quantitative LC-MS/MS. In addition, the LC-HRMS workflow using data-dependent MS2 acquisition was applied to a small subset of 20 selected plasma samples to provide first insights into a broader chemical exposure characterization through suspect screening and non-targeted analysis (NTA). The targeted analyses revealed that most mycotoxin exposure biomarkers were absent in the samples. However, ochratoxin A was quantified in all breast milk and plasma samples (median values of 43 ng/L and 135 ng/L) and in 27% of urine samples (median: 20 ng/L). Citrinin was detected in 34% of breast milk and 6% of stool samples (median values of 10 ng/L and 2.5 ng/g). Alternariol monomethyl ether was detected in 94% of breast milk, 12% of stool, and 31% of tested urine specimens (median values of 1.2 ng/L, 1.2 ng/g, and 12 ng/L). In the non-targeted analysis, 356 features were annotated with confidence Levels 2a, 2b, and 3, while 20 compounds were identified at Level 1 with authentic reference standards. This included key toxicants like per- and polyfluorinated substances (PFAS), bisphenol A, cotinine, and phthalates. Albeit a small cohort, this study demonstrated that extremely premature infants were exposed to a mixture of dietary, environmental, and lifestyle-related exposures. While many of the analyzed mycotoxins, including the carcinogenic aflatoxins, were not detected and indicated low overall mycotoxin exposure, plastics- and industry-related chemicals were detected at comparatively high levels, warranting further investigation into their potential health implications.
No takes yet. Share an insight, caveat, or question.
Ayeni et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: